Search Results - "Ocak, Birol"

Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy by Şahin, Ahmet Bilgehan, Cubukcu, Erdem, Ocak, Birol, Deligonul, Adem, Oyucu Orhan, Sibel, Tolunay, Sahsine, Gokgoz, Mustafa Sehsuvar, Cetintas, Sibel, Yarbas, Gorkem, Senol, Kazım, Goktug, Mehmet Refik, Yanasma, Zeki Burak, Hasanzade, Ulviyya, Evrensel, Turkkan

“…Blood-based biomarkers reflect systemic inflammation status and have prognostic and predictive value in solid malignancies. As a recently defined biomarker,…”
Get full text

Hyperprogression and hypercalcemia after nivolumab treatment in three cases with renal cell carcinoma by Caner, Burcu, Ertas, Hulya, Ocak, Birol, Cubukcu, Erdem

“…Introduction Hyperprogression is a specific type of response seen with immunotherapy that is observed in all malignancies with a frequency of 9% - 29%,…”
Get full text

Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma? by Ocak, Birol, Sahin, Ahmet Bilgehan, Ertürk, Ismail, Korkmaz, Mustafa, Erdem, Dilek, Cakıroglu, Umut, Karaca, Mustafa, Dirican, Ahmet, Olmez, Omer Fatih, Goktas Aydın, Sabin, Gökyer, Ali, Kücükarda, Ahmet, Gülmez, Ahmet, Yumuk, Perran Fulden, Demircan, Nazim Can, Oyman, Abdilkerim, Sakalar, Teoman, Karatas, Fatih, Demir, Hacer, Yasin, Ayse Irem, Deligonul, Adem, Dakiki, Bahar, Goktug, Mehmet Refik, Avcı, Okan, Tacar, Seher Yildiz, Turhal, Nazım Serdar, Deniz, Gülhan Ipek, Kacan, Turgut, Cubukcu, Erdem, Evrensel, Türkkan

“…This study aimed to investigate the effect of cytoreductive nephrectomy (CN) on the survival outcomes of nivolumab used as a subsequent therapy after the…”
Get full text

Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: A single-center retrospective real-world data by Oyucu Orhan, Sibel, Bilgehan Sahin, Ahmet, Cubukcu, Erdem, Deligonul, Adem, Ocak, Birol, Orhan, Bedrettin, Evrensel, Turkkan

“…Kaposi sarcoma is a rare disease and there is a gap in the literature about which chemotherapeutics should be applied, especially for the classical type. We…”
Get full text

The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans by Adem, Deligonul, Yazici, Serkan, Ozsen, Mine, Cetintas, Sibel Kahraman, Yalcinkaya, Ulviye, Şahin, Ahmet Bilgehan, Tanrıverdi, Ozgur, Orhan, Sibel Oyucu, Ocak, Birol, Cubukcu, Erdem, Kahveci, Ramazan, Evrensel, Turkkan

“…Dermatofibrosarcoma protuberans (DFSP) is an uncommon soft tissue sarcoma that originates from the dermis or subcutaneous tissue in the skin. While its…”
Get full text

The impact of Ki-67 index, squamous differentiation, and several clinicopathologic parameters on the recurrence of low and intermediate-risk endometrial cancer by Ocak, Birol, Atalay, Fatma Öz, Sahin, Ahmet Bilgehan, Ozsen, Mine, Dakiki, Bahar, Türe, Seray, Mesohorli, Merve, Odman, Hikmet Utku, Tanrıverdi, Özgür, Ocakoğlu, Gökhan, Bayrak, Mehmet, Ozan, Hakan, Demiröz, Candan, Sali, Seda, Orhan, Sibel Oyucu, Deligönül, Adem, Cubukcu, Erdem, Evrensel, Türkkan

“…Endometrial endometrioid carcinoma (EEC) represents approximately 75-80% of endometrial carcinoma cases. Three hundred and thirty-six patients with EEC…”
Get full text

Altmışbeş Yaş Üstü Metastatik Yumuşak Doku Sarkom Hastalarında Pazopanib Tedavisinin Etkinliğinin Retrospektif Değerlendirilmesi by ÇUBUKÇU, Erdem, OCAK, Birol

“…Yumuşak doku sarkomları (YDS) mezenşimal hücrelerden köken alan tümörlerin nadir ve heterojen grububudur ve tüm erişkin kanserlerin yaklaşık %1 ini…”
Get full text

The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer by Emirzeoglu, Levent, Arici, Serdar, Sahin, Ahmet Bilgehan, Ocak, Birol, Ak, Naziye, Ay, Seval, Mammadov, Elkhan, Turna, Hande, Bilici, Ahmet

“…Abstract Purpose: The aim of the study was to investigate the effects of body mass index (BMI) on the response to neoadjuvant chemotherapy (NACT) in Turkish…”
Get full text

Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2 by Ünsal, Oktay, Yazıcı, Ozan, Özdemir, Nuriye, Çubukçu, Erdem, Ocak, Birol, Üner, Aytuğ, Özet, Ahmet

“…The objective of this study was to evaluate the clinical and laboratory outcomes of solid cancer patients who were reinfected with COVID-19. Patients who…”
Get full text

Peritumoral and Intratumoral Lymphocytic Infiltration and Stromal Reaction in High-Risk Endometrioid Carcinomas

Get full text

Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study by Bilici, Ahmet, Koca, Sinan, Karaagac, Mustafa, Eraslan, Emrah, Ocak, Birol, Goktas Aydin, Sabin, Sezgin Goksu, Sema, Paydas, Semra, Derin, Sumeyye, Ergun, Yakup, Yekegunduz, Emre, Erol, Cihan, Tataroglu Ozyukseler, Deniz, Demiray, Atike Gokcen, Karaca, Mustafa, Guc, Zeynep Gulsum, Menekse, Serkan, Yesil Cinkir, Havva, Gumusay, Ozge, Sakin, Abdullah

“…e23542 Background: Soft tissue sarcomas (STS) are a heterogenous group of tumors which have limited therapeutic options and poor prognosis in…”
Get full text

Early thrombocytopenia predicts longer time‑to‑treatment discontinuation in trastuzumab emtansine treatment by Sahin, Ahmet Bilgehan, Caner, Burcu, Ocak, Birol, Gulmez, Ahmet, Hamitoglu, Buket, Cubukcu, Erdem, Deligonul, Adem, Orhan, Sibel Oyucu, Canhoroz, Mustafa, Odman, Hikmet Utku, Somali, Isil, Ocakoglu, Gokhan, Evrensel, Turkkan

“…Thrombocytopenia is a characteristic adverse event of trastuzumab emtansine (T-DM1), one of the essential treatment options for human epithelial growth factor…”
Get full text

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study by Bilici, Ahmet, Koca, Sinan, Karaagac, Mustafa, Aydin, Sabin Goktas, Eraslan, Emrah, Kaplan, Muhammed Ali, Ocak, Birol, Goksu, Sema Sezgin, Paydas, Semra, Akgul, Fahri, Derin, Sumeyye, Ergun, Yakup, Yekeduz, Emre, Erol, Cihan, Ozyukseler, Deniz Tataroglu, Demiray, Atike Gokcen, Karaca, Mustafa, Guc, Zeynep Gulsum, Menekse, Serkan, Cinkir, Havva Yesil, Gumusay, Ozge, Sakin, Abdullah, Ozkul, Ozlem, Demir, Hacer, Erdem, Dilek, Besiroglu, Mehmet, Unal, Olcun Umit, Acar, Ramazan, Koral, Lokman, Sahin, Suleyman, Sakalar, Teoman, Bahceci, Aykut, Ozveren, Ahmet, Gunaydin, Ulug Mutlu, Seker, Mehmet Metin, Sunar, Veli, Dal, Pinar, Artac, Mehmet, Turhal, Serdar

“…Aim Description of patient characteristics, effectiveness and safety in Turkish patients treated with pazopanib for metastatic soft tissue sarcoma (STS)…”
Get full text

Retrospective Comparison of the Efficacy of Therapeutic Agents in Metastatic Soft-Tissue Sarcomas by caner, burcu

Get full text

Chemotherapy plus radiotherapy vs. radiotherapy alone in high-risk endometrioid endometrial carcinoma by Sahin, A B, Ocak, B, Abakay, C D, Cubukcu, E, Deligonul, A, Caner, B, Dakiki, B, Islek, G, Ozerkan, K, Evrensel, T

“…Adding chemotherapy to radiotherapy in patients with high-risk endometrioid endometrial cancer (EEC) remains controversial, particularly in stages I-II. We…”
Get more information

Chemo-Immunotherapy with Atezolizumab in Extensive-Stage Small-Cell Lung Cancer; Single-Center Experience by SAHIN, AHMET BILGEHAN

Get full text

Why do some patients with stage 1A and 1B endometrial endometrioid carcinoma experience recurrence? A retrospective study in search of prognostic factors by Ocak, Birol, Sahin, Ahmet Bilgehan, Oz Atalay, Fatma, Ozsen, Mine, Dakiki, Bahar, Ture, Seray, Sali, Seda, Tanriverdi, Ozgur, Bayrak, Mehmet, Ozan, Hakan, Demiroz Abakay, Candan, Deligonul, Adem, Cubukcu, Erdem, Evrensel, Turkkan

“…OBJECTIVES: Endometrial endometrioid carcinoma (EEC) is the most encountered subtype of endometrial cancer (EC). Our study aimed to investigate the factors…”
Get full text

Malign Peritoneal Mezotelyoma Hastalarının Retrospektif Değerlendirilmesi by OCAK, Birol, ŞAHİN, Ahmet Bilgehan, DAKİKİ, Bahar, ODMAN, Hikmet, DELİGÖNÜL, Adem, ÇUBUKÇU, Erdem, EVRENSEL, Türkkan

“…ilişkilendirilmiştir. Malign peritoneal mezotelyoma (MPM) plevral tutulumdan sonra ikinci sıklıkta görülür. Çalışmamızda MPM tanısı alan hastalarda demografik…”
Get full text

Radiotherapy could increase the efficacy of immunotherapy in non-small cell lung cancer by OCAK, Birol, SARIHAN, Süreyya, ŞAHİN, Ahmet Bilgehan, DAKİKİ, Bahar, CANER, Burcu, GÜLŞEN, Kemal, TANRIVERDİ, Özgür, DELİGÖNÜL, Adem, ÇUBUKÇU, Erdem, EVRENSEL, Türkkan

“…Background: In non-small cell lung cancer (NSCLC), immunotherapy is a treatment option in patients without targetable mutations in second and later lines…”
Get full text

Metastatik Endometrioid Endometrial Karsinom Hastalarında Tedavi Seçeneklerinin Sağkalım Üzerine Etkisi by OCAK, Birol, ŞAHİN, Ahmet Bilgehan, DEMİRÖZ ABAKAY, Candan, SALİ, Seda, DAKİKİ, Bahar, İŞLEK, Gizem, CANER, Burcu, ÖZERKAN, Kemal, DELİGÖNÜL, Adem, ÇUBUKÇU, Erdem, EVRENSEL, Türkkan

“…Endometrium kanseri (EK) gelişmiş ülkelerde en sık görülen jinekolojik kanserdir. Obezite en önemli risk faktörü olarak kabul edilmektedir. Endometrium…”
Get full text